• helpDesk@lucintel.com
  • |
  • Llamar a Lucintel +1 972 636 5056
  • |
  • Acceso
  • |
  • Registro
  • |
  • Buscar
  • |
'
...

The Impact of COVID-19 is included in Aptamer Market.

Buy it today to get an advantage. Request the impact of COVID-19 on your product or industry


The future of the global aptamer market looks promising with opportunities in diagnostic, therapeutic development, and research & development applications. The global aptamer market is expected to grow with a CAGR of 18%-20% from 2020 to 2025. The major drivers for this market are increasing research and development activities in biotechnology and pharmaceutical companies and the low cost and high efficiency of aptamers as compared to antibodies.

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global aptamer market report, please download the report brochure.

 
 
 
 
 
In this market, nucleic aptamer is the largest type segment of aptamer, whereas diagnostics is the largest application. Growth in various segments of the aptameter market are given below:



 



The study includes trends and forecast for the global aptamer market by type, technology, application, end user, and region as follows:
 
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Nucleic Acid Aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers
  • Peptide Aptamers

By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Systemic Evolution of Ligands by Exponential Enrichment (SELEX)
  • Other Technologies

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Diagnostics
  • Therapeutic Development
  • Research and Development
  • Other Applications

By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Academic and Government Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Contract Research Organizations
  • Other End Users

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • América del norte
    • Estados Unidos
    • Canadá 
    • México
  • Europa
    • Reino Unido
    • Alemania
    • Francia
  • Asia Pacífico
    • Porcelana
    • India
    • Japón
  • The Rest of the World
    • Brasil
 

Some of the aptamer companies profiled in this report include AM Biotechnologies, Aptagen, Aptamer Sciences, Aptamer Solutions, Aptus Biotech, Base Pair Biotechnologies, NeoVentures Biotechnology, SomaLogic, TriLink BioTechnologies, and Vivonics.

Lucintel forecasts that nucleic aptamers will remain the largest type segment over the forecast period, as it has better thermodynamic and chemical stability as compared to peptide therapeutics.

Within this market, diagnostics will remain the largest application segment over the forecast period due to increasing prevalence of chronic diseases.

North America will remain the largest region over the forecast period due to increasing investment by biotechnology and pharmaceutical indusries in research and development activities related to aptamers and increasing number of research laboratories in the region. 





 
Features of the Global Aptamer Market
 
  • Market Size Estimates: Global aptamer market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global aptamer market size by various segments, such as type, technology, application, and end user in terms of value.
  • Regional Analysis: Global aptamer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, technology, application, end user, and region for the global aptamer market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global aptamer market.
  • Análisis de la intensidad competitiva de la industria basada en el modelo de cinco fuerzas de Porter.



 
This report answers following key questions

  Q.1 What are some of the most promising potential, high-growth opportunities for the global aptamer market by type (nucleic acid aptamers [DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers] and peptide aptamers), technology (SELEX and other technologies), application (diagnostics, therapeutic development, research and development, and other applications), end user (academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global aptamer market?
Q.5 What are the business risks and threats to the global aptamer market?
Q.6 What are the emerging trends in this aptamer market and the reasons behind them?
Q.7 What are some changing demands of customers in this aptamer market?
Q.8 What are the new developments in this aptamer market? Which companies are leading these developments?
Q.9 Who are the major players in this aptamer market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this aptamer market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global aptamer market?

 



Report Scope



Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)		 2014-2019
Forecast Period 2020-2025
Páginas More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Type (Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers) and Peptide Aptamers), Technology (SELEX and Other Technologies), Application (Diagnostics, Therapeutic Development, Research & Development, and Other Applications), and End User (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Other End Users)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost

Tabla de contenido


1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Aptamer Market Trends and Forecast
3.3: Global Aptamer Market by Type
3.3.1: Nucleic Acid Aptamers 
3.3.1.1: DNA-Based Aptamers
3.3.1.2: RNA-Based Aptamers
3.3.1.3: XNA-Based Aptamers
3.3.2: Peptide Aptamers 
3.4: Global Aptamer Market by Technology
3.4.1: Systemic Evolution of Ligands by Exponential Enrichment (SELEX) 
3.4.2: Other Technologies 
3.5: Global Aptamer Market by Application
3.5.1: Diagnostics
3.5.2: Therapeutic Development
3.5.3: Research and Development
3.5.4: Other Applications
3.5: Global Aptamer Market by End User
3.5.1: Academic and Government Research Institutes
3.5.2: Biotechnology and Pharmaceutical Companies
3.5.3: Contract Research Organizations
3.5.4: Other End Users

4. Market Trends and Forecast Analysis by Region
4.1: Global Aptamer Market by Region
4.2: North American Aptamer Market
4.2.1: Market by Type: Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers) and Peptide Aptamers
4.2.2: Market by Technology: Systemic Evolution of Ligands by Exponential Enrichment (SELEX) and Other Technologies 
4.2.3: Market by Application: Diagnostics, Therapeutic Development, Research and Development, and Other Applications
4.2.4: Market by End User: Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Other End Users 
4.2.5: The United States Aptamer Market
4.2.6: The Canadian Aptamer Market
4.2.7: The Mexican Aptamer Market
4.3: European Aptamer Market
4.3.1: Market by Type: Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers) and Peptide Aptamers 
4.3.2: Market by Technology: Systemic Evolution of Ligands by Exponential Enrichment (SELEX) and Other Technologies 
4.3.3: Market by Application: Diagnostics, Therapeutic Development, Research and Development, and Other Applications 
4.3.4: Market by End User: Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Other End Users 
4.3.5: The Aptamer Market of United Kingdom
4.3.6: The German Aptamer Market
4.3.7: The French Aptamer Market
4.4: APAC Aptamer Market
4.4.1: Market by Type: Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers) and Peptide Aptamers 
4.4.2: Market by Technology: Systemic Evolution of Ligands by Exponential Enrichment (SELEX) and Other Technologies 
4.4.3: Market by Application: Diagnostics, Therapeutic Development, Research and Development, and Other Applications 
4.4.4: Market by End User: Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Other End Users 
4.4.5: The Chinese Aptamer Market
4.4.6: The Indian Aptamer Market
4.4.7: The Japanese Aptamer Market
4.5: ROW Aptamer Market
4.5.1: Market by Type: Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers) and Peptide Aptamers 
4.5.2: Market by Technology: Systemic Evolution of Ligands by Exponential Enrichment (SELEX) and Other Technologies 
4.5.3: Market by Application: Diagnostics, Therapeutic Development, Research and Development, and Other Applications 
4.5.4: Market by End User: Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Other End Users 
4.5.5: Brazilian Aptamer Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Aptamer Market by Type
7.1.2: Growth Opportunities for the Global Aptamer Market by Technology
7.1.3: Growth Opportunities for the Global Aptamer Market by Application
7.1.4: Growth Opportunities for the Global Aptamer Market by End User
7.1.5: Growth Opportunities for the Global Aptamer Market by Region
7.2: Emerging Trends in the Global Aptamer Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Aptamer Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Aptamer Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: AM Biotechnologies, LLC 
8.2: Aptagen, LLC
8.3: Aptamer Sciences, Inc.
8.4: Aptamer Solutions Ltd.
8.5: Aptus Biotech S.L. 
8.6: Base Pair Biotechnologies, Inc. 
8.7: NeoVentures Biotechnology
8.8: SomaLogic Inc. 
8.9: TriLink BioTechnologies, Inc. 
8.10: Vivonics, Inc.
 
.

Comprar un informe completo o por capítulo de la siguiente manera

Oferta por tiempo limitado

Precio por tipo de licencia:
[-] ocultar detalles del capítulo
[Número de capítulo] [Nombre del capítulo] [Capítulo Número de páginas] [Precio del capítulo]
Nombre del título/capítulo Páginas Precio
Full Report: Aptamer Market: Trends, Forecast and Competitive Analysis Informe completo $ 2,990
150 - page report
Lucintel ha estado en el negocio de la consultoría de investigación y gestión de mercado desde 2000 y ha publicado más de 1000 informes de inteligencia de mercado en varios mercados / aplicaciones y atendió a más de 1,000 clientes en todo el mundo. Este estudio es una culminación de cuatro meses de esfuerzo a tiempo completo realizado por el equipo analista de Lucintel. Los analistas utilizaron las siguientes fuentes para la creación y finalización de este valioso informe:
  • Entrevistas en profundidad de los principales actores en este mercado
  • Investigación secundaria detallada de los estados financieros de los competidores y datos publicados 
  • Extensas búsquedas de obras publicadas, mercado e información de bases de datos relacionadas con noticias de la industria, comunicados de prensa de la empresa e intenciones de clientes
  • Una compilación de las experiencias, juicios e ideas de los profesionales de Lucintel, que han analizado y rastreado este mercado a lo largo de los años.
Se realizan una extensa investigación y entrevistas en la cadena de suministro de este mercado para estimar la cuota de mercado, el tamaño del mercado, las tendencias, los impulsores, los desafíos y las previsiones. A continuación se muestra un breve resumen de las entrevistas principales que se llevaron a cabo por la función de trabajo para este informe.
 
Por lo tanto, Lucintel compila grandes cantidades de datos de numerosas fuentes, valida la integridad de esos datos y realiza un análisis exhaustivo. Lucintel luego organiza los datos, sus hallazgos y las ideas sobre un informe conciso diseñado para respaldar el proceso estratégico de toma de decisiones. La siguiente figura es una representación gráfica del proceso de investigación de Lucintel. 
 

Please sign in below to get report brochure - Aptamer Market.

En Lucintel, respetamos su privacidad y mantenemos la confidencialidad de la información / datos proporcionados por usted
(Ingrese su correo electrónico corporativo. * Estos campos son obligatorios)
¿Tiene una cuenta / visitantes que devuelven?

Séguenos